AAAAAA

   
Results: 1-9 |
Results: 9
DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND DISTRIBUTION OF HISTOLOGICAL SUBTYPES IN 196 PATIENTS (PTS) - THE EXPERIENCE OF THE DEPARTMENT OFMEDICAL ONCOLOGY, EVANGELISMOS-HOSPITAL, ATHENS, GREECE
Authors: VASLAMATZIS M XYNOGALOS S RONTOGIANNI D VARTHALITIS J MESISKLIS P VAMVOUKA C ALEXOPOULOS CG
Citation: M. Vaslamatzis et al., DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND DISTRIBUTION OF HISTOLOGICAL SUBTYPES IN 196 PATIENTS (PTS) - THE EXPERIENCE OF THE DEPARTMENT OFMEDICAL ONCOLOGY, EVANGELISMOS-HOSPITAL, ATHENS, GREECE, Annals of oncology, 9, 1998, pp. 513-513
PACLITAXEL IN CISPLATIN OR CARBOPLATIN-PRETREATED OVARIAN-CANCER - PHASE-II STUDY
Authors: PECTASIDES D PAPADOPOULOU M VARTHALITIS J MYLONAKIS A KOSTOPOULOU M DIMITRIADIS M ATHANASSIOU A
Citation: D. Pectasides et al., PACLITAXEL IN CISPLATIN OR CARBOPLATIN-PRETREATED OVARIAN-CANCER - PHASE-II STUDY, Oncology, 55(3), 1998, pp. 228-234
CHEMOTHERAPY WITH METHOTREXATE, CARBOPLATIN, MITOXANTRONE (NOVANTRONE) AND VINCRISTINE (ONCOVIN) IN TRANSITIONAL-CELL UROTHELIAL CANCER
Authors: PECTASIDES D MYLONAKIS A ANTONIOU F KOSTOPOULOU M TRIANTAPHYLLIS D PAPADOPOULOU M VARTHALITIS J DIMITRIADIS M ATHANASSIOU A
Citation: D. Pectasides et al., CHEMOTHERAPY WITH METHOTREXATE, CARBOPLATIN, MITOXANTRONE (NOVANTRONE) AND VINCRISTINE (ONCOVIN) IN TRANSITIONAL-CELL UROTHELIAL CANCER, Oncology, 55(2), 1998, pp. 139-144
AN OUTPATIENT PHASE-II STUDY OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN COMBINATION WITH INTRAVENOUS VINBLASTINE IN METASTATIC RENAL-CELL CANCER
Authors: PECTASIDES D VARTHALITIS J KOSTOPOULOU M MYLONAKIS A TRIANTAPHYLLIS D PAPADOPOULOU M DIMITRIADIS M ATHANASSIOU A
Citation: D. Pectasides et al., AN OUTPATIENT PHASE-II STUDY OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN COMBINATION WITH INTRAVENOUS VINBLASTINE IN METASTATIC RENAL-CELL CANCER, Oncology, 55(1), 1998, pp. 10-15
SUPERIORITY OF CARBOPLATIN MONOCHEMOTHERAPY OVER CARBOPLATIN-BASED POLYCHEMOTHERAPY IN OVARIAN-CANCER
Authors: ATHANASSIOU A VARTHALITIS J TSAVARIS N DIMITRIDIS M MOUTZOURIDIS G
Citation: A. Athanassiou et al., SUPERIORITY OF CARBOPLATIN MONOCHEMOTHERAPY OVER CARBOPLATIN-BASED POLYCHEMOTHERAPY IN OVARIAN-CANCER, European journal of gynaecological oncology, 18(5), 1997, pp. 420-425
CEA, CA-19-9, AND CA-50 IN MONITORING GASTRIC-CARCINOMA
Authors: PECTASIDES D MYLONAKIS A KOSTOPOULOU M PAPADOPOULOU M TRIANTAFILLIS D VARTHALITIS J DIMITRIADES M ATHANASSIOU A
Citation: D. Pectasides et al., CEA, CA-19-9, AND CA-50 IN MONITORING GASTRIC-CARCINOMA, American journal of clinical oncology, 20(4), 1997, pp. 348-353
COMPARISON OF 2 DIFFERENT DOSES OF ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS
Authors: PECTASIDES D MYLONAKIS A VARTHALITIS J KOSTOPOULOU M CONSTANTINOU A PAPAZACHARIOU K ANTONIOU F DIMITRIADIS M ATHANASSIOU A
Citation: D. Pectasides et al., COMPARISON OF 2 DIFFERENT DOSES OF ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Oncology, 54(1), 1997, pp. 1-6
TPA, TATI, CEA, AFP, BETA-HCG, PSA, SCC, AND CA-19-9 FOR MONITORING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: PECTASIDES D BAFALOUCOS D ANTONIOU F GOGOU L ECONOMIDES N VARTHALITIS J DIMITRIADES M KOSMIDIS P ATHANASSIOU A
Citation: D. Pectasides et al., TPA, TATI, CEA, AFP, BETA-HCG, PSA, SCC, AND CA-19-9 FOR MONITORING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, American journal of clinical oncology, 19(3), 1996, pp. 271-277
CHEMOTHERAPY FOR MERKEL-CELL-CARCINOMA WITH CARBOPLATIN AND ETOPOSIDE
Authors: PECTASIDES D MOUTZOURIDES G DIMITRIADIS M VARTHALITIS J ATHANASSIOU A
Citation: D. Pectasides et al., CHEMOTHERAPY FOR MERKEL-CELL-CARCINOMA WITH CARBOPLATIN AND ETOPOSIDE, American journal of clinical oncology, 18(5), 1995, pp. 418-420
Risultati: 1-9 |